GALLI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.780
EU - Europa 1.455
AS - Asia 972
SA - Sud America 101
OC - Oceania 26
AF - Africa 22
Totale 5.356
Nazione #
US - Stati Uniti d'America 2.767
RU - Federazione Russa 566
SG - Singapore 291
CN - Cina 233
HK - Hong Kong 204
SE - Svezia 168
PL - Polonia 138
UA - Ucraina 126
IE - Irlanda 121
IT - Italia 98
KR - Corea 93
DE - Germania 88
BR - Brasile 79
FI - Finlandia 56
IN - India 39
GB - Regno Unito 38
VN - Vietnam 38
JO - Giordania 37
FR - Francia 33
AU - Australia 25
TR - Turchia 9
CA - Canada 8
SC - Seychelles 8
CI - Costa d'Avorio 7
CO - Colombia 4
EC - Ecuador 4
MX - Messico 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BE - Belgio 3
EE - Estonia 3
ID - Indonesia 3
IQ - Iraq 3
JP - Giappone 3
SA - Arabia Saudita 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
ES - Italia 2
PE - Perù 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
Totale 5.356
Città #
Santa Clara 694
Ashburn 255
Fairfield 203
Singapore 196
Jacksonville 194
Hong Kong 175
Chandler 174
Warsaw 137
Dublin 121
Cambridge 109
Seattle 99
Seoul 93
Woodbridge 84
Wilmington 82
Hefei 79
Houston 71
Beijing 53
Buffalo 48
San Jose 43
Ann Arbor 40
Altamura 34
Los Angeles 34
Princeton 34
Boardman 33
The Dalles 32
Boston 28
Melbourne 25
Lawrence 24
Mumbai 21
Paris 20
Kent 19
San Diego 17
Shanghai 17
Turku 16
Moscow 15
Dong Ket 14
Munich 14
Washington 14
Medford 13
Ho Chi Minh City 12
New York 11
São Paulo 11
Dallas 10
Milan 8
West Jordan 8
Abidjan 7
Auburn Hills 7
Council Bluffs 7
Florence 7
Salerno 7
Helsinki 6
Hillsboro 6
Izmir 6
Andover 5
Chennai 5
Frankfurt Am Main 5
Frankfurt am Main 5
Hanoi 5
Norwalk 5
Chicago 4
London 4
Montreal 4
Philadelphia 4
Secaucus 4
St Louis 4
Brussels 3
Puducherry 3
Redondo Beach 3
Stockholm 3
Tallinn 3
Tokyo 3
Amman 2
Baku 2
Barcelona 2
Bengaluru 2
Bogotá 2
Guayaquil 2
Haiphong 2
Jakarta 2
Khobar 2
Lima 2
Loudi 2
Maringá 2
Mexico City 2
Montevideo 2
Pilāni 2
Prato 2
San Francisco 2
Toronto 2
Uberlândia 2
Verona 2
Yubileyny 2
Afyonkarahisar 1
Arcoverde 1
Astana 1
Atlanta 1
Auckland 1
Baghdad 1
Berlin 1
Bern 1
Totale 3.609
Nome #
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 308
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 222
ANTINOCICEPTIVE ACTIVITY OF A 3(2H)-PYRIDAZINONE DERIVATE IN MICE 195
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation and molecular modeling study 187
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 185
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists 174
4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones. Excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity 172
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 169
Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. 168
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists 167
Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological and Molecular Modeling Studies 166
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 165
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: synthesis and structure-activity relationships 165
SYNTHESIS AND BINDING STUDY OF PYRAZOLO[4,5-C][1,8]NAPHTHYRIDINES. 163
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-AMINOPHTHALAZINIUM SALTS AS GABAA RECEPTOR ANTAGONISTS. 162
Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity. 162
“3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists” 161
7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists. 157
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 149
Benzodiazepine binding activity of some tricyclic heteroarometic systems to define the hydrogen bonding strength of the proton donors of the receptor site. 148
Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. 143
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 140
Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs 138
Synthesis and Pharmacological Studies at the Gly/NMDA, AMPA and Kainate Receptors of New Oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring 136
Tandem 3D-QSARs Approach as a Valuable Tool To Predict Binding Affinity Data: Design of New Gly/NMDA Receptor Antagonists as a Key Study. 133
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. 129
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity. 124
Synthesis, Ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogue of TQX-173 121
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazolin-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. 110
Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation. 106
Tricyclic Heteroaromatic systems. 3-Substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]quinoxalines as novel antagonists at the glycine-NMDA site. 99
Synthesis of 2-substituted-3,4-dihydro-3-oxo-6,8-dichloro-2H-1,4-benzothiazin-1,1-dioxides and 1-oxides as glycine-NMDA receptor antagonists. 96
Synthesis and structure-activity relationships of 1-aminophthalazinium bromides as GABAA receptor ligands. 94
Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and their constrained analogue imidazo[1,5-a]quinoxalines-1,3,4-triones as selective Glycine/NMDA receptor antagonists. 94
Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report 88
The guinea pig myenteric plexus as a tool to characterize drugs active at the glycine recognition site of the NMDA receptors. 79
Totale 5.375
Categoria #
all - tutte 13.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 5 34 24 45 20 48
2021/2022218 6 24 9 11 8 7 8 16 10 5 66 48
2022/2023677 57 116 27 49 69 111 78 33 111 3 19 4
2023/2024267 9 32 48 17 19 56 10 43 3 8 13 9
2024/20251.739 52 164 90 221 549 274 13 143 54 54 71 54
2025/20261.023 232 255 144 61 206 63 62 0 0 0 0 0
Totale 5.375